UOsaka’s CAMaD selected for AMED SCARDA Program on R&D Platform Project for Medical Countermeasures against Infectious Disease Emergencies

UOsaka’s Center for Advanced Modalities and Drug Delivery System (CAMaD) has been newly selected for the R&D Platform Project for Medical Countermeasures against Infectious Disease Emergencies, implemented by the Strategic Center of Biomedical Advanced Vaccine Research and Development for Preparedness and Response (SCARDA) of the Japan Agency for Medical Research and Development (AMED).

Established in October 2022 as UOsaka’s vaccine development center, CAMaD was selected as a Synergy Hub under AMED SCARDA’s Program for the Formation of World-Leading Research and Development Centers for Vaccine Development, which was launched in accordance with the Japan’s Strategy for Strengthening the Vaccine Development and Production System adopted by the Cabinet in June 2021.

With this new selection, CAMaD will expand its ongoing vaccine research and development efforts to promote the integrated research and development of medical countermeasures (MCMs) for infectious disease emergencies, including therapeutics and diagnostics. Research activities are scheduled to begin in mid-July 2026.

Through this initiative, CAMaD will establish an integrated R&D platform that covers the entire continuum of infectious disease preparedness and response, including prevention by vaccines, early detection through diagnostic technologies, and the prevention and treatment of severe disease through therapeutics. The program will support research and development ranging from basic research through the completion of non-clinical studies.

CAMaD will further enhance its R&D framework for preparedness against infectious disease emergencies during peacetime, while advancing the infrastructure needed for a rapid response to future pandemics.

〈Related Links〉
・AMED SCARDA Program on R&D Platform Project for Medical Countermeasures against Infectious Disease Emergencies
・Vaccines Development Center, Center for Advanced Modalities and Drug Delivery System, The University of Osaka